Why the study?
Vasovagal syncope is a common and challenging clinical condition where severe recurrent episodes can cause physical injury and psychological distress.
This review provides an overview of management strategies for vasovagal syncope, focusing on therapeutic modalities such as closed loop stimulation and cardioneuroablation.
Answers are grounded in this paper and cite their sources.
Provides synthesis for refractory vasovagal syncope management; leaves open efficacy of closed-loop stimulation and cardioneuroablation pending randomized trials.
Vasovagal syncope (VVS) (or neurocardiogenic syncope) is a common clinical condition that is challenging to both physicians and patients alike. Severe episodes of recurrent syncope can result in physical injury as well as psychological distress. This article provides a brief overview of current management strategies and a detailed overview of therapeutic modalities such as closed loop stimulation (CLS) and cardioneuroablation (CNA).
No takes yet. Share an insight, caveat, or question.
Ali et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: